"Designing Growth Strategies is in our DNA"

Hospital at Home Platforms Market Size, Share, and Industry Analysis, By Component (Software/Platforms, Connected Devices & Kits, Services/Implementation, and Others), By Care Model (Acute Hospital-at-Home, Post-acute/ Step-Down Care, Chronic Care at Home, and Others), By Technology (Remote Patient Monitoring, Care Coordination & Command Center, Telehealth/Virtual Visits, Logistics & Medication Management, and Others), By End User (Hospitals & Health Systems, Home Health Providers, Payers/ Risk-bearing Organizations, and Others), and Regional Forecast till 2034

Region : Global | Report ID: FBI119214 | Status : Ongoing

 

KEY MARKET INSIGHTS

The global hospital at home platforms market was valued at USD 3.20 billion in 2025. The market is projected to grow from USD 3.88 billion in 2026 to USD 18.00 billion by 2034, exhibiting a CAGR of 21.2% during the forecast period.

The global market is an emerging area within digital health, gaining momentum as healthcare providers shift suitable acute and post-acute care from hospital facilities to patients’ homes. These platforms help hospitals manage remote monitoring, virtual consultations, care coordination, medication support, clinical escalation, and patient engagement through a connected system. These platforms help hospitals address rising bed capacity pressure and workforce shortages. Hospital-at-home platforms also support value-based care by helping reduce avoidable admissions, shorten hospital stays, improve patient comfort, and lower overall care delivery costs. As reimbursement models, remote monitoring tools, and health-system partnerships continue to improve, these platforms are expected to become an important part of modern hospital operations and home-based acute care delivery.

  • For instance, in March 2026, Current Health, a clinical platform powering hospital-level care-at-home models, announced that Cardinal Health’s Velocare solution offered last-mile fulfilment, installation and retrieval of Current Health’s in-home clinical monitoring kits, streamlining patient onboarding for hospital-at-home programs. This collaboration helps health systems to lower program costs and reduce vendor complexity. Such development helps reduce patient onboarding delays, lowers operational pressure on clinical teams, and supports faster scaling of hospital-level care in home settings.

Furthermore, funding initiatives, technological advancements, strategic collaborations and new product launches by key operating companies strengthen their market position and support global market growth.

Hospital at Home Platforms Market Driver

Increasing Burden of Chronic Diseases and Aging Population to Expand Need for Remote Care Platforms

One of the prominent factors driving the market growth is the rising burden of chronic diseases and the aging population. These patient groups often require continuous monitoring, timely clinical intervention, and frequent follow-up care, elevating the global product demand. As more patients live with conditions such as heart failure, COPD, diabetes, and post-acute complications, hospitals are under pressure to manage care beyond the inpatient setting. Hospital-at-home platforms help address this need by integrating remote patient monitoring, virtual visits, alerts, care coordination, and escalation workflows into a single system. These features enable healthcare providers to detect changes in patient condition earlier, reduce avoidable hospital visits, and support safer recovery at home. Highlighting these factors, key companies in the market are expanding their capabilities for hospital-at-home platforms.

  • For instance, in March 2025, Medical Guardian expanded its remote monitoring capabilities to strengthen chronic disease management and reduce hospital readmissions. The at-home health monitoring devices provide healthcare providers and health plans with actionable insights to detect health trends early, support timely interventions, and reduce preventable hospitalizations. Such connected monitoring solutions are being used to manage chronic patients at home and reduce pressure on hospital infrastructure.

Download Free sample to learn more about this report.

According to a survey published by Vivalink, Inc., in June 2024, more than 300 Hospital at Home (HaH) programs were approved across the U.S., allowing thousands of patients to be monitored in the comfort of their homes after leaving the hospital. In the survey conducted, 49% of respondents who had participated in a HaH program found  remote patient monitoring (RPM) device easy to use. It also reported that urban participants were more likely to have participated in HaH programs (71% vs. 25% among rural respondents) but were less likely to prefer completely remote primary care than rural participants.

Hospital at Home Platforms Market Restraint

Limited Reimbursement Clarity May Restrict Wider Platform Adoption

Limited reimbursement clarity is significantly restraining the growth of the market. Hospitals need predictable payment models before making long-term investments in technology, staffing, remote monitoring devices, and home-based clinical operations. This slows vendor adoption as hospital-at-home platforms require integration with EHRs, logistics partners, clinical command centers, and reimbursement workflows before they can be used at scale. This creates planning uncertainty for hospitals and limits faster global market expansion.

  • For instance, in March 2025, Inbound Health stated that a six-month hospital-at-home waiver extension was a short-term step forward. However, without a permanent solution, patient access remained uncertain, and health systems still had to make difficult investment decisions amid policy instability.

Hospital at Home Platforms Market Opportunity

Expansion of Virtual Wards to Create New Growth Opportunities

The expansion of virtual wards is creating significant growth opportunities for market players, as hospitals increasingly use home-based models to reduce inpatient crowding and improve patient flow. As virtual wards enable suitable patients to receive hospital-level monitoring and clinical support at home, healthcare providers need integrated platforms to manage remote vitals, alerts, virtual consultations, care-team workflows, and escalation protocols. These factors create demand for hospital-at-home platforms that can support both acute care and step-down recovery pathways. As a result, platform vendors can expand from small pilots to long-term health-system contracts and regional care-at-home programs.

  • For instance, in April 2025, NHS Greater Glasgow and Clyde announced a partnership with Doccla to create Scotland’s largest virtual hospital, with plans for 1,000 virtual ward beds to support patients at home and free up acute hospital capacity. Such developments are creating greater demand for hospital-at-home platforms.

Segmentation

By Component

By Care Model

By Technology

By End User

By Region

·      Software/Platforms

·      Connected Devices & Kits

·      Services/Implementation

·      Others

·      Acute Hospital-at-Home

·      Post-acute/Step-Down Care

·      Chronic Care at Home

·      Others

·      Remote Patient Monitoring

·      Care Coordination & Command Center

·      Telehealth/Virtual Visits

·      Logistics & Medication Management

·      Others

·      Hospitals & Health Systems

·      Home Health Providers

·      Payers/ Risk-bearing Organizations

·      Others

·      North America (U.S. and Canada)

·      Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and the Rest of Europe)

·      Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)

·      Latin America (Brazil, Mexico, and the Rest of Latin America)

·      Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)

Key Insights

The report covers the following key insights:

  • Overview of Technological Advancement
  • Regulatory Scenario, By Key Countries/Regions
  • New Product Launches, By Key Players
  • Key Industry Developments (Strategic Partnerships, Acquisitions, and Mergers)
  • Key Start Ups, By Key Regions

Analysis by Component

Based on component, the global hospital at home platforms market is segmented into software/platforms, connected devices & kits, services/implementation, and others.

Among these, software/platforms dominates the market, as hospital-at-home programs depend on a central digital layer to manage workflows. As hospitals expand virtual care and home-based acute care, they require platforms that integrate remote monitoring, video visits, command-center workflows, and care-team communication into a single system. These factors create a stronger demand for software/platforms, resulting in a dominant share. Increasing investment in these components by key companies further strengthens segment growth.

  • For instance, in September 2025, Caregility raised USD 25.0 million to drive the future of hospital-based virtual care. The Caregility Connected Care platform supports clinical and operational applications across the care continuum, including care delivery from the hospital to the home.

Analysis by Care Model

Based on care model, the market is segmented into acute hospital-at-home, post-acute/step-down care, chronic care at home, and others.

The acute hospital-at-home segment holds the largest share of the market. It directly addresses challenges with limited inpatient capacity. The care model allows clinically eligible patients to receive hospital-level care at home while freeing beds for more critical in-facility cases. Acute hospital-at-home creates a stronger economic and operational case by reducing avoidable admissions, shortening inpatient stays, and improving patient flow. Hospitals also prioritize acute-care substitution and participating in strategic collaborations to reduce pressure on emergency departments and wards.

  • For instance, in November 2024, Biofourmis collaborated with Lee Health, a health system comprised of five hospitals across Southwest Florida, to launch Hospital at Home, a home-based hospital care model, and to expand its remote patient monitoring (RPM) program to support patients across the continuum.

Analysis by Technology

Based on technology, the market is segmented into remote patient monitoring, care coordination & command center, telehealth/virtual visits, logistics & medication management, and others.

The remote patient monitoring segment dominates the market. It provides continuous visibility into patient health in hospital-at-home care. Hospitals need real-time or near-real-time data on vital signs, symptoms, oxygen levels, activity, and risk of clinical deterioration before they can confidently manage acute patients outside the hospital. Without remote monitoring, virtual visits and care coordination alone cannot provide the clinical oversight required for hospital-level care at home. As a result, RPM has become the most widely adopted technology layer across. The increasing use of connected devices, wearable sensors, and centralized monitoring dashboards also supports its dominance.

  • For instance, in September 2025, Masimo announced findings from a study showing that continuous patient monitoring technologies, including Masimo SET pulse oximetry and Patient SafetyNet, were associated with improved clinical outcomes and projected cost savings. These instances demonstrate the dominance of remote patient monitoring and the need for timely intervention.

Analysis by End User

Based on end user, the market is segmented into hospitals & health systems, home health providers, payers/ risk-bearing organizations, and others.

The hospitals & health systems segment dominates the market as they are the primary organizations responsible for acute-care delivery, patient triage, clinical governance, staffing, and reimbursement. These institutions face direct pressure from bed shortages, emergency department crowding, rising patient volumes, and workforce constraints, making home-based hospital care a strategic priority. As hospital-at-home shifts from pilot programs to larger system-wide deployments, this end-user group is expected to remain the leading revenue contributor.

  • For instance, in May 2026, Philips announced that a Philips-led consortium had been selected to support Region Stockholm’s hospital-at-home initiative, enabling hospital-level care to be delivered to up to 15,000 patients annually in their homes. This development supports the dominance of hospitals & health systems given that large hospital-led and region-wide programs are becoming major buyers of hospital-at-home technology infrastructure.

Regional Analysis

Request for Customization   to gain extensive market insights.

On the basis of region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for approximately 58.0% of the global hospital at home platforms market in 2025. The regional market is depicting rapid expansion given that hospitals are under pressure to manage bed shortages, emergency department crowding, rising care costs, and workforce constraints. The region has also benefited from stronger reimbursement momentum, especially in the region. As more health systems treat eligible acute patients at home, demand is increasing for platforms that can connect patient monitoring, virtual visits, care coordination, and escalation pathways. As a result, North America remains one of the most advanced regions for hospital-at-home platform adoption.

  • For instance, in June 2025, DispatchHealth merged with Medically Home to create a national platform for complex care at home. The development aimed to bring together clinical care, Technology, logistics, and scale to simplify how serious health needs are treated at home. This development supports North America’s market growth by demonstrating rising investment in integrated platforms that can support high-acuity hospital-at-home care across health systems.

The Europe market is expected to grow at a significant CAGR during the forecast period. Many European countries face aging populations, long waiting lists, workforce shortages, and rising inpatient demand, which creates a strong need for home-based acute and step-down care models. Hospital-at-home platforms help these systems monitor patients remotely, coordinate multidisciplinary teams, and manage clinical escalation without keeping every patient inside the hospital. This is encouraging health systems to move from small pilots toward larger regional virtual ward programs.

  • For instance, in January 2026, the Innovative Health Initiative (IHI) commenced the HospitalAtHome project, bringing together healthcare institutions and technology companies including Erasmus MC, Philips, Region Stockholm, Leiden University Medical Center, and Aarhus University Hospital to develop scalable hospital-at-home models across Europe. The initiative, supported by approximately USD 16.60 million in EU funding, aims to develop solutions capable of reaching at least one million patients across more than 10 European countries, highlighting the increasing institutional focus on technology-enabled home-based acute care.

The Asia Pacific market is expected to grow at a stable CAGR during the forecast period. Healthcare systems are facing a dual challenge of rising chronic disease burden and uneven access to hospital-based specialist care. Emerging economies are increasing the use of connected devices, remote monitoring, telehealth, and AI-based triage to extend care beyond hospitals. Hospital-at-home platforms can help providers monitor patients remotely, identify deterioration earlier, support virtual consultations, and reduce unnecessary hospital visits. As digital infrastructure improves and companies invest in remote care partnerships, the Asia Pacific is expected to offer strong long-term growth opportunities.

  • For instance, in November 2025, OMRON Healthcare announced an investment in Tricog Health to advance AI-powered cardiac care. The partnership would help bring advanced remote patient monitoring services and early detection to patients nationwide. This development supports Asia Pacific’s market growth by demonstrating how regional digital health partnerships are expanding remote monitoring capabilities that can support home-based and hospital-at-home care models.

Key Players Covered

The global hospital at home platforms market is moderately fragmented but increasingly consolidating.

The report includes the profiles of the following key players:

  • DispatchHealth (U.S.)
  • Current Health (U.S.)
  • Contessa Health, Inc. (U.S.)
  • Biofourmis Inc. (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • Caregility Corporation (U.S.)
  • Huma Therapeutics Limited (U.K.)
  • Doccla (U.K.)
  • Masimo Corporation (U.S.)
  • Health Recovery Solutions, Inc. (U.S.)

Key Industry Developments

  • March 2026: Stryker announced its new SmartHospital Platform, a digital foundation designed to connect devices, data, and care teams across the hospital into one intelligent, adaptive ecosystem.
  • August 2024: LG Electronics launched Primefocus Health. This new venture aims to leverage innovative technologies and new healthcare therapies to enable providers to deliver a personalized, complete care experience and empower individuals to take control of their health at home.


  • Ongoing
  • 2025
  • 2021-2024
  • Special Price

    (Offer valid till 15th Oct 2026)

Download Free Sample

    man icon
    Mail icon
    Mail icon
Jump to Content

Get 30-60 hrs Free Customization

Expand Regional and Country Coverage, Segments Analysis, Company Profiles, Competitive Benchmarking, and End-user Insights.

Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann